483 Boehringer Ingelheim Pharma & KG Mar 2016

483 Boehringer Ingelheim Pharma & KG Mar 2016

Michael Charles FDA, Roger Zabinski FDA$595.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Pharma & KG - Ingelheim am Rhein, Germany facility and issued 10 inspectional observations (via FDA 483) on 08 Mar 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 10
  • Inspection end: 08 Mar 2016
  • Location: Ingelheim am Rhein, Germany
  • FEI: 3002806556
Add To Cart